{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T19:25:00Z","timestamp":1772911500524,"version":"3.50.1"},"reference-count":39,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>Early postprandial hyperglycemia and delayed hypoglycemia remain major problems in current management of type 1 diabetes (T1D).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>Our objective was to investigate the effects of pramlintide, known to suppress glucagon and delay gastric emptying, on postprandial glucose fluxes in T1D.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design:<\/jats:title>\n                  <jats:p>This was a single-center, inpatient, randomized, crossover study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients:<\/jats:title>\n                  <jats:p>Twelve patients with T1D who completed the study were analyzed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Interventions:<\/jats:title>\n                  <jats:p>Subjects were studied on two occasions with or without pramlintide. Triple tracer mixed-meal method and oral minimal model were used to estimate postprandial glucose turnover and insulin sensitivity (SI). Integrated liver insulin sensitivity was calculated based on glucose turnover. Plasma glucagon and insulin were measured.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measure:<\/jats:title>\n                  <jats:p>Glucose turnover and SI were the main outcome measures.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>With pramlintide, 2-hour postprandial glucose, insulin, glucagon, glucose turnover, and SI indices showed: plasma glucose excursions were reduced (difference in incremental area under the curve [iAUC], 444.0 mMmin, P = .0003); plasma insulin concentrations were lower (difference in iAUC, 7642.0 pMmin; P = .0099); plasma glucagon excursions were lower (difference in iAUC, 1730.6 pg\/mlmin; P = .0147); meal rate of glucose appearance was lower (difference in iAUC: 1196.2 \u03bcM\/kg fat free mass [FFM]; P = .0316), endogenous glucose production was not different (difference in iAUC: \u2212105.5 \u03bcM\/kg FFM; P = .5842), rate of glucose disappearance was lower (difference in iAUC: 1494.2 \u03bcM\/kg FFM; P = .0083). SI and liver insulin sensitivity were not different between study visits (P &amp;gt; .05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>Inhibition of glucagon and gastric emptying delaying reduced 2-hour prandial glucose excursions in T1D by delaying meal rate of glucose appearance.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2015-3952","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T18:00:53Z","timestamp":1456855253000},"page":"1954-1962","source":"Crossref","is-referenced-by-count":30,"title":["Effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes"],"prefix":"10.1210","volume":"101","author":[{"given":"Ling","family":"Hinshaw","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism (L.H., V.D., A.M., R.B., A.B., Y.C.K.), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Schiavon","sequence":"additional","affiliation":[{"name":"Department of Information Engineering (M.S., C.D.M., C.C.), University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikash","family":"Dadlani","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism (L.H., V.D., A.M., R.B., A.B., Y.C.K.), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwini","family":"Mallad","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism (L.H., V.D., A.M., R.B., A.B., Y.C.K.), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Dalla Man","sequence":"additional","affiliation":[{"name":"Department of Information Engineering (M.S., C.D.M., C.C.), University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adil","family":"Bharucha","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism (L.H., V.D., A.M., R.B., A.B., Y.C.K.), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Basu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism (L.H., V.D., A.M., R.B., A.B., Y.C.K.), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Geske","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research (J.R.G., R.E.C.), Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rickey E.","family":"Carter","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research (J.R.G., R.E.C.), Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Cobelli","sequence":"additional","affiliation":[{"name":"Department of Information Engineering (M.S., C.D.M., C.C.), University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananda","family":"Basu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology (A.B.), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogish C.","family":"Kudva","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism (L.H., V.D., A.M., R.B., A.B., Y.C.K.), Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071615360990300_B1","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.2337\/dc13-2066","article-title":"Closed-loop artificial pancreas systems: physiological input to enhance next-generation devices","volume":"37","author":"Kudva","year":"2014","journal-title":"Diabetes Care"},{"key":"2020071615360990300_B2","first-page":"168","article-title":"Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device","volume":"14","author":"Cengiz","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"2020071615360990300_B3","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2337\/db12-1759","article-title":"Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system","volume":"62","author":"Hinshaw","year":"2013","journal-title":"Diabetes"},{"key":"2020071615360990300_B4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1152\/ajpendo.00190.2001","article-title":"Use of a novel triple-tracer approach to assess postprandial glucose metabolism","volume":"284","author":"Basu","year":"2003","journal-title":"Am J Physiol (Endocrinol Metab)"},{"key":"2020071615360990300_B5","doi-asserted-by":"crossref","first-page":"E494","DOI":"10.1152\/ajpendo.00199.2014","article-title":"Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and beta-cell function","volume":"307","author":"Hinshaw","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071615360990300_B6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2265.2008.03351.x","article-title":"Relationship between clinical features and gastric emptying disturbances in diabetes mellitus","volume":"70","author":"Bharucha","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071615360990300_B7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/oby.2007.626","article-title":"Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects","volume":"15","author":"Chapman","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"2020071615360990300_B8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1399-5448.2008.00430.x","article-title":"Gastric emptying and postprandial glucose excursions in adolescents with type 1 diabetes","volume":"9","author":"Heptulla","year":"2008","journal-title":"Pediatr Diabetes"},{"key":"2020071615360990300_B9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2337\/diabetes.54.4.1100","article-title":"The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes","volume":"54","author":"Heptulla","year":"2005","journal-title":"Diabetes"},{"key":"2020071615360990300_B10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0140-6736(90)90197-D","article-title":"Islet-amyloid polypeptide in human plasma","volume":"335","author":"van Jaarsveld","year":"1990","journal-title":"Lancet"},{"key":"2020071615360990300_B11","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.2337\/diabetes.53.suppl_3.S233","article-title":"Amylin agonists: a novel approach in the treatment of diabetes","volume":"3","author":"Schmitz","year":"2004","journal-title":"Diabetes"},{"key":"2020071615360990300_B12","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1021\/acs.biochem.5b00567","article-title":"Analysis of the ability of pramlintide to inhibit amyloid formation by human islet amyloid polypeptide reveals a balance between optimal recognition and reduced amyloidogenicity","volume":"54","author":"Wang","year":"2015","journal-title":"Biochemistry"},{"key":"2020071615360990300_B13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1210\/en.2013-1658","article-title":"Activity of pramlintide, rat and human amylin but not Abeta1\u201342 at human amylin receptors","volume":"155","author":"Gingell","year":"2014","journal-title":"Endocrinology"},{"key":"2020071615360990300_B14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/protein\/gzp029","article-title":"Solution state structures of human pancreatic amylin and pramlintide","volume":"22","author":"Cort","year":"2009","journal-title":"Protein Eng Des Sel"},{"key":"2020071615360990300_B15","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1152\/ajpendo.00514.2007","article-title":"Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans","volume":"294","author":"Woerle","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071615360990300_B16","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2337\/dc07-2446","article-title":"Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide","volume":"31","author":"Woerle","year":"2008","journal-title":"Diabetes Care"},{"key":"2020071615360990300_B17","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"2020071615360990300_B18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-nutr-071812-161201","article-title":"Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose","volume":"34","author":"Hayes","year":"2014","journal-title":"Annu Rev Nutr"},{"key":"2020071615360990300_B19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1109\/10.995680","article-title":"The oral glucose minimal model: estimation of insulin sensitivity from a meal test","volume":"49","author":"Dalla Man","year":"2002","journal-title":"IEEE Trans Biomed Eng"},{"key":"2020071615360990300_B20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0026-0495(88)90033-9","article-title":"The disposal of an oral glucose load in patients with non-insulin-dependent diabetes","volume":"37","author":"Ferrannini","year":"1988","journal-title":"Metabolism"},{"key":"2020071615360990300_B21","doi-asserted-by":"crossref","first-page":"E637","DOI":"10.1152\/ajpendo.00319.2003","article-title":"Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method","volume":"287","author":"Dalla Man","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071615360990300_B22","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1152\/ajpendo.00358.2014","article-title":"Hepatic insulin sensitivity in healthy and prediabetic subjects: from a dual- to a single-tracer oral minimal model","volume":"309","author":"Visentin","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071615360990300_B23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-111-8-671","article-title":"A patient questionnaire to identify bowel disease","volume":"111","author":"Talley","year":"1989","journal-title":"Ann Intern Med"},{"key":"2020071615360990300_B24","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2337\/dc08-1826","article-title":"Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness and postprandial glucose metabolism","volume":"32","author":"Basu","year":"2009","journal-title":"Diabetes Care"},{"key":"2020071615360990300_B25","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2337\/diabetes.50.6.1351","article-title":"Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity","volume":"50","author":"Basu","year":"2001","journal-title":"Diabetes"},{"key":"2020071615360990300_B26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/pst.185","article-title":"Sample size of 12 per group rule of thumb for a pilot study","volume":"4","author":"Julious","year":"2005","journal-title":"Pharm Stat"},{"key":"2020071615360990300_B27","article-title":"Statistical Rules of Thumb","author":"van Belle","year":"2008","edition":"2nd edition"},{"key":"2020071615360990300_B28","article-title":"Cross-over Trials in Clinical Research","author":"Senn","year":"2002","edition":"2nd edition"},{"key":"2020071615360990300_B29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3181\/00379727-147-38286","article-title":"Concentrations of glucagon and the insulin:glucagon ratio in the portal and peripheral circulation","volume":"147","author":"Felig","year":"1974","journal-title":"Proc Soc Exp Biol Med"},{"key":"2020071615360990300_B30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1463-1326.2011.01454.x","article-title":"Physiologic action of glucagon on liver glucose metabolism","volume":"1","author":"Ramnanan","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"2020071615360990300_B31","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0016-5085(83)80027-4","article-title":"Pancreatic polypeptide: a hormone under vagal control","volume":"85","author":"Schwartz","year":"1983","journal-title":"Gastroenterology"},{"key":"2020071615360990300_B32","doi-asserted-by":"crossref","unstructured":"Williams\n              JA\n            \n          . 2014. Pancreatic Polypeptide. The Pancreapedia: Exocrine Pancreas Knowledge Base. http:\/\/www.pancreapedia.org. doi:10.3998\/panc.2014.4.","DOI":"10.3998\/panc.2014.4"},{"key":"2020071615360990300_B33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0025-6196(12)60319-X","article-title":"Can plasma human pancreatic polypeptide be used to detect diseases of the exocrine pancreas?","volume":"60","author":"Koch","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"2020071615360990300_B34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000198787","article-title":"Effect of somatostatin on fasting and glucose-stimulated gastric inhibitory polypeptide release in man","volume":"24","author":"Salera","year":"1982","journal-title":"Digestion"},{"key":"2020071615360990300_B35","doi-asserted-by":"crossref","first-page":"G946","DOI":"10.1152\/ajpgi.2000.278.6.G946","article-title":"Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition","volume":"278","author":"Samsom","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2020071615360990300_B36","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1210\/jc.2009-2133","article-title":"Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?","volume":"95","author":"Asmar","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615360990300_B37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1467-789X.2006.00270.x","article-title":"The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review","volume":"8","author":"Klok","year":"2007","journal-title":"Obes Rev"},{"key":"2020071615360990300_B38","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1371\/journal.pmed.0010062","article-title":"Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index","volume":"1","author":"Taheri","year":"2004","journal-title":"PLoS Med"},{"key":"2020071615360990300_B39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yfrne.2004.03.002","article-title":"Ghrelin\u2013a hormone with multiple functions","volume":"25","author":"Korbonits","year":"2004","journal-title":"Front Neuroendocrinol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/5\/1954\/10427685\/jcem1954.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/5\/1954\/10427685\/jcem1954.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T02:43:15Z","timestamp":1594953795000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/101\/5\/1954\/2804749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,1]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2015-3952","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,1]]}}}